Novel use of combined 5-HT1A agonists and selective serotonin reuptake inhibitors

Details for Australian Patent Application No. 2002221803 (hide)

Owner Merck Patent GmbH

Inventors Sedman, Ewen; Bartoszyk, Gerd

Agent Davies Collison Cave

Pub. Number AU-B-2002221803

PCT Pub. Number WO02/39989

Priority 00125409 20.11.00 EP

Filing date 2 November 2001

Wipo publication date 27 May 2002

Acceptance publication date 15 February 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/4045 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

15 February 2007 Application Accepted

  Published as AU-B-2002221803

14 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002221804

2002221802